Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

The European Commission (EC) has outlined three measures it is taking to advise companies on how they may cooperate with each other in addressing potential drug shortages relating to the novel coronavirus (COVID-19) while maintaining compliance...

Eli Lilly and Company and Sitryx, an Oxford, UK-based biopharmaceutical company focused on developing therapeutics in immuno-oncology and immuno-inflammation, have entered a licensing pact in a deal worth up to $880 million ($50 million...

Takeda has formed a licensing pact with Evox Therapeutics, an Oxford, UK-headquartered biopharmaceutical company, in a deal worth up to $882 million ($44 million upfront) for the development of protein-replacement and mRNA therapies. The...

A roundup of developments from India (Bayer, GSK), the US (Boehringer Ingelheim, Lilly, Tetraphase, Amicus), and Japan (Amgen). India Bayer, Curadev Sign Agreement To Develop STING Antagonists Program Bayer and Curadev, a small-molecule...